Chambers Rebecca
- SEC CIK
- 0001823563
In the past year, 5 open-market sale filings worth $1.91M and no purchases.
Current role at each company
- VCYT Veracyte, Inc.Chief Financial Officeras of Sep 4, 2026
- ALMR Alamar Biosciences, Inc.Directoras of Apr 20, 2026
- NARI Inari Medical, Inc.Directoras of Feb 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.91M
- 5 filings
- Net
- −$1.91M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Chambers Rebecca as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VCYT Veracyte, Inc.
Chief Financial Officer8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 (view filing) | Nov 12 | 2 days | Chambers RebeccaChief Financial Officer | SSale | −15.3K | $38.34 | −$585.6K | −10.9%124.5K after | 10b5-1 |
| Dec 4, 2024 (view filing) | Dec 3 | 1 day | Chambers RebeccaChief Financial Officer | SSale | −7.00K | $43.23 | −$302.6K | −5.8%114.0K after | 10b5-1 |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Chambers RebeccaChief Financial Officer | SSale | −527 | $43.85 | −$23.1K | −0.5%113.5K after | 10b5-1 |
| Nov 7, 2025 (view filing) | Nov 5 | 2 days | Chambers RebeccaChief Financial Officer | SSale | −7.00K | $41.00 | −$287.0K | −5.3%126.2K after | 10b5-1 |
| Dec 4, 2025 (view filing) | Dec 4 | Same day | Chambers RebeccaChief Financial Officer | SSale | −13.3K | $46.84 | −$621.9K | −10.8%109.5K after | 2 lots10b5-1 |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Chambers RebeccaChief Financial Officer | SSale | −18.3K | $36.14 | −$662.9K | −12.3%131.2K after | 2 lots10b5-1 |
| Jun 4, 2026 (view filing) | Jun 4 | Same day | Chambers RebeccaChief Financial Officer | SSale | −3.56K | $49.73 | −$177.1K | −2.0%173.3K after | 2 lots10b5-1 |
| Sep 4, 2026 (view filing)7:54 PM ET | Sep 4 | Same day | Chambers RebeccaChief Financial Officer | SSale | −3.65K | $43.10 | −$157.4K | −2.2%166.0K after | 2 lots10b5-1 |
NARI Inari Medical, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 (view filing) | May 20 | 1 day | Chambers RebeccaDirector | SSale | −964 | $45.39 | −$43.8K | −8.8%9.94K after | 10b5-1 |
| Jun 24, 2024 (view filing) | Jun 21 | 3 days | Chambers RebeccaDirector | SSale | −260 | $45.99 | −$12.0K | −2.6%9.68K after | 10b5-1 |